StockData
NervGen Pharma Corp. logo

NervGen Pharma Corp. (NGEN) KPIs and segments

NGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.96+0.14 (+7.69%)

Close on Nov 17, 2026Market cap $156.11MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive NervGen Pharma's business

Coming soon

This tab will track the numbers specific to NervGen Pharma's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?